J. Chana

Basic science232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function

H. L. Wright, R. Moots, T. Spector, 2012 .

Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England

C. Cooper, M. Javaid, A. Judge, 2014, Osteoporosis International.

Hip fracture as the tracer condition.

C. Cooper, J. Chana, M. Kassim Javaid, 2013, Best practice & research. Clinical rheumatology.

Warfarin, head injury and bruising

M. Wallace, A. Chan, J. Chana, 2010, BMJ Case Reports.

An unusual complication of ice skating and the emergence of a previously undiagnosed bleeding disorder

J. Chana, J. Pleydell-Pearce, C. Mainwaring, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Bedside testing for myasthenia gravis: the ice-test

J. Booth, M. Wallace, J. Chana, 2011, Emergency Medicine Journal.

Bedside testing for myasthenia gravis: the ice-test

J. Booth, M. Wallace, J. Chana, 2010, BMJ Case Reports.

Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool

C. Cooper, J. Kanis, M. Javaid, 2015, Osteoporosis International.

Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England

Sally Sheard, J. Chana, C. Cooper, 2014, Osteoporosis International.